InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Swirsky Douglas J, Director. Officer active across 2 companies, notably Cellectar Biosciences, Inc.. Aggregated, 5 disclosures have been published. Split: 2 buys · 1 sell. Total volume traded: €64k. Activity tracked since 14 September 2021. The latest transaction was filed on 18 March 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
5 of 5 declarations
Douglas J. Swirsky is a Board Member at Cellectar Biosciences, Inc. He plays an important role in overseeing the company's activities and developing its growth strategy.